ALPS Advisors’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-47,460
| Closed | -$102K | – | 1044 |
|
|
2025
Q1 | $102K | Sell |
47,460
-4,130
| -8% | -$8.88K | ﹤0.01% | 979 |
|
|
2024
Q4 | $200K | Buy |
+51,590
| New | +$200K | ﹤0.01% | 972 |
|
|
2016
Q4 | – | Sell |
-2,903
| Closed | -$115K | – | 722 |
|
|
2016
Q3 | $115K | Sell |
2,903
-290
| -9% | -$11.5K | ﹤0.01% | 668 |
|
|
2016
Q2 | $229K | Buy |
3,193
+641
| +25% | +$46K | ﹤0.01% | 596 |
|
|
2016
Q1 | $205K | Sell |
2,552
-438
| -15% | -$35.2K | ﹤0.01% | 603 |
|
|
2015
Q4 | $226K | Sell |
2,990
-545
| -15% | -$41.2K | ﹤0.01% | 669 |
|
|
2015
Q3 | $13.6K | Buy |
3,535
+1,312
| +59% | +$5.03K | 0.01% | 196 |
|
|
2015
Q2 | $924K | Buy |
2,223
+1,139
| +105% | +$473K | 0.01% | 216 |
|
|
2015
Q1 | $515K | Buy |
+1,084
| New | +$515K | ﹤0.01% | 507 |
|